Pharmacokinetic Drug Interactions MCQs

Welcome to our comprehensive collection of Multiple Choice Questions (MCQs) on Pharmacokinetic Drug Interactions, a fundamental topic in the field of Drug and Pharmaceutical Biotechnology. Whether you're preparing for competitive exams, honing your problem-solving skills, or simply looking to enhance your abilities in this field, our Pharmacokinetic Drug Interactions MCQs are designed to help you grasp the core concepts and excel in solving problems.

In this section, you'll find a wide range of Pharmacokinetic Drug Interactions mcq questions that explore various aspects of Pharmacokinetic Drug Interactions problems. Each MCQ is crafted to challenge your understanding of Pharmacokinetic Drug Interactions principles, enabling you to refine your problem-solving techniques. Whether you're a student aiming to ace Drug and Pharmaceutical Biotechnology tests, a job seeker preparing for interviews, or someone simply interested in sharpening their skills, our Pharmacokinetic Drug Interactions MCQs are your pathway to success in mastering this essential Drug and Pharmaceutical Biotechnology topic.

Note: Each of the following question comes with multiple answer choices. Select the most appropriate option and test your understanding of Pharmacokinetic Drug Interactions. You can click on an option to test your knowledge before viewing the solution for a MCQ. Happy learning!

So, are you ready to put your Pharmacokinetic Drug Interactions knowledge to the test? Let's get started with our carefully curated MCQs!

Pharmacokinetic Drug Interactions MCQs | Page 3 of 4

Discover more Topics under Drug and Pharmaceutical Biotechnology

Q21.
Which of the following is not a characteristic of the caternary compartment model?

a.

It gives a visual representation of various rate processes in drug disposition

b.

It shows how many rate constants are necessary

c.

Compartments and parameters bear a relationship with physiologic functions

d.

Useful in predicting drug

Discuss
Answer: (c).Compartments and parameters bear a relationship with physiologic functions
Q22.
In noncompartmental analysis, Mean residence time is equal to _____________

a.

The area under the first moment curve/area under the zero moment curve

b.

The area under the zero moment’s curve/area under the first moment curve

c.

1 / Area under the first-moment curve

d.

1/ Area under the zero moment curve

Discuss
Answer: (a).The area under the first moment curve/area under the zero moment curve
Q23.
Which pharmacokinetic model is drawn on the basis of anatomic and physiologic data?

a.

Compartment model

b.

Caternary model

c.

Physiologic model

d.

Mammillary model

Discuss
Answer: (c).Physiologic model
Q24.
Which of the following will be a disadvantage for the physiologic model?

a.

Prediction of drug concentration in various body regions

b.

Correlation of data in several animal species

c.

Obtaining experimental data for each of the organs

d.

The model gives an exact description of the drug concentration-time profile for any organ

Discuss
Answer: (c).Obtaining experimental data for each of the organs
Q25.
Which model is also known as membrane permeation rate limited?

a.

Physiologic model

b.

Compartment model

c.

Noncompartment model

d.

Mammillary model

Discuss
Answer: (a).Physiologic model
Q26.
In plasma drug concentration versus time graph as shown in the picture, what should be the correct option for the marked place?

a.

Maximum safe concentration

b.

Minimum effective concentration

c.

Therapeutic range

d.

Onset of action

Discuss
Answer: (a).Maximum safe concentration
Q27.
In plasma drug concentration versus time graph as shown in the picture, what should be the correct option for the marked place?

a.

Maximum safe concentration

b.

Minimum effective concentration

c.

Therapeutic range

d.

Onset of action

Discuss
Answer: (b).Minimum effective concentration
Q28.
In plasma drug concentration versus time graph as shown in the picture, what should be the correct option for the marked place?

a.

Elimination phase

b.

Post absorption phase

c.

Absorption phase

d.

Duration of action

Discuss
Answer: (b).Post absorption phase
Q29.
In plasma drug concentration versus time graph as shown in the picture, what should be the correct option for the marked place?

a.

Elimination phase

b.

Post absorption phase

c.

Absorption phase

d.

Duration of action

Discuss
Answer: (c).Absorption phase
Q30.
In plasma drug concentration versus time graph as shown in the picture, what should be the correct option for the marked place?

a.

Elimination phase

b.

Post absorption phase

c.

Absorption phase

d.

Duration of action

Discuss
Answer: (a).Elimination phase
Page 3 of 4